Nagi Bioscience launches exclusive Priority Access Program, bringing revolutionary SydLab™ One platform to five leading academic labs for C. elegans research

Nagi Bioscience, a pioneer Swiss company pioneer in cutting-edge laboratory technologies for alternative model organisms research, proudly announces the launch of its exclusive Priority Access Program, providing access to five leading academic laboratories to the first-of-its-kind SydLab™ One platform.

Flagship recruits former BMS, Celgene R&D chief Rupert Vessey

After leaving his post as the head of research at Bristol Myers Squibb, Rupert Vessey is joining venture firm Flagship Pioneering. Vessey will become an

July 13, 2023

INTEGRA Biosciences’ pipettes help to advance cancer drug discovery

The Institute for Cancer Research (ICR), part of the University of London, is using VIAFLO electronic pipettes from INTEGRA Biosciences to streamline its preclinical drug

June 20, 2023

Getinge’s heart assist pump shutdown problem given FDA Class I recall tag

Dive Brief: The U.S. Food and Drug Administration has categorized Getinge’s latest heart assist pump safety notice as a Class I recall. Getinge sent an

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.